1
|
Ticiani E, Pu Y, White M, Adomshick V, Veiga-Lopez A. Organotin mixtures reveal interactions that modulate adipogenic differentiation in 3T3-L1 preadipocytes. Arch Toxicol 2023; 97:1649-1658. [PMID: 37142754 PMCID: PMC10424724 DOI: 10.1007/s00204-023-03512-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Accepted: 04/26/2023] [Indexed: 05/06/2023]
Abstract
Organotin chemicals (butyltins and phenyltins) are the most widely used organometallic chemicals worldwide and are used in industrial applications, such as biocides and anti-fouling paints. Tributyltin (TBT) and more recently, dibutyltin (DBT) and triphenyltin (TPT) have been reported to stimulate adipogenic differentiation. Although these chemicals co-exist in the environment, their effect in combination remains unknown. We first investigated the adipogenic effect of eight organotin chemicals (monobutyltin (MBT), DBT, TBT, tetrabutyltin (TeBT), monophenyltin (MPT), diphenyltin (DPT), TPT, and tin chloride (SnCl4)) in the 3T3-L1 preadipocyte cell line in single exposures at two doses (10 and 50 ng/ml). Only three out of the eight organotins induced adipogenic differentiation with TBT eliciting the strongest adipogenic differentiation (in a dose-dependent manner) followed by TPT and DBT, as demonstrated by lipid accumulation and gene expression. We then hypothesized that, in combination (TBT, DBT, and TPT), adipogenic effects will be exacerbated compared to single exposures. However, at the higher dose (50 ng/ml), TBT-induced differentiation was reduced by TPT and DBT when in dual or triple combination. We tested whether TPT or DBT would interfere with adipogenic differentiation stimulated by a peroxisome proliferator-activated receptor (PPARγ) agonist (rosiglitazone) or a glucocorticoid receptor agonist (dexamethasone). Both DBT50 and TPT50 reduced rosiglitazone-, but not dexamethasone-stimulated adipogenic differentiation. In conclusion, DBT and TPT interfere with TBT's adipogenic differentiation possibly via PPARγ signaling. These findings highlight the antagonistic effects among organotins and the need to understand the effects and mechanism of action of complex organotin mixtures on adipogenic outcomes.
Collapse
Affiliation(s)
- Elvis Ticiani
- Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA
| | - Yong Pu
- Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA
| | - Madison White
- Department of Animal Science, Michigan State University, East Lansing, MI, USA
| | - Victoria Adomshick
- Department of Animal Science, Michigan State University, East Lansing, MI, USA
| | - Almudena Veiga-Lopez
- Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
- Department of Animal Science, Michigan State University, East Lansing, MI, USA.
| |
Collapse
|
2
|
Merlo E, Zimerman J, Dos Santos FCF, Zanol JF, da Costa CS, Carneiro PH, Miranda-Alves L, Warner GR, Graceli JB. Subacute and low dose of tributyltin exposure leads to brown adipose abnormalities in male rats. Toxicol Lett 2023; 376:26-38. [PMID: 36638932 PMCID: PMC9928871 DOI: 10.1016/j.toxlet.2023.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Revised: 01/07/2023] [Accepted: 01/09/2023] [Indexed: 01/12/2023]
Abstract
Tributyltin (TBT) is an obesogenic endocrine disrupting chemical (EDC) linked with several metabolic complications. Brown adipose tissue (BAT) is the principal site for thermogenesis, making it a potential target for obesity management and metabolic disease. However, few studies have evaluated TBT effect on BAT function. In this investigation, we assessed whether subacute (15 days) and low dose of TBT exposure (100 ng/kg/day) results in abnormal BAT morphophysiology in adult male rats. Body temperature, BAT morphology, inflammation, oxidative stress, collagen deposition and BAT metabolic gene expression markers were assessed in room temperature (Room, ∼24 ºC) and after cold tolerance test (Cold, ∼4 ºC) conditions. A reduction in body temperature was observed in both Room and Cold conditions in TBT rats, suggesting abnormal BAT thermogenic function. Changes in BAT morphology were observed in TBT rats, with an increase in BAT lipid accumulation, an increase in BAT unilocular adipocyte number and a decrease in BAT multilocular adipocyte number in Room condition. All these parameters were opposite in Cold condition TBT rats, leading to a borderline increase in BAT UCP1 protein expression. An increase in BAT mast cell number was observed in TBT rats in Room condition. An increase in ED1 protein expression (macrophage marker) was observed in TBT rats in Cold condition. Oxidative stress and collagen deposition increased in both Room and Cold conditions in TBT rats. TBT exposure caused a borderline increase in BAT COL1A1 protein expression in Cold condition. Further, strong negative correlations were observed between body temperature and BAT lipid accumulation, and BAT lipid accumulation and multilocular adipocyte number. Thus, these data suggest that TBT exposure impaired BAT morphophysiology through impacts on lipid accumulation, inflammation, fibrosis and oxidative stress in male rats.
Collapse
Affiliation(s)
- Eduardo Merlo
- Department of Morphology, Federal University of Espírito Santo, Vitória, Brazil
| | - Jeanini Zimerman
- Department of Morphology, Federal University of Espírito Santo, Vitória, Brazil
| | | | - Jordana F Zanol
- Department of Morphology, Federal University of Espírito Santo, Vitória, Brazil
| | - Charles S da Costa
- Department of Morphology, Federal University of Espírito Santo, Vitória, Brazil
| | - Pedro H Carneiro
- Experimental Endocrinology Research, Development and Innovation Group, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Brazil; Postgraduate Program in Endocrinology, School of Medicine, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, Ilha do Governador, Cidade Universitária, UFRJ, RJ, Brazil
| | - Leandro Miranda-Alves
- Experimental Endocrinology Research, Development and Innovation Group, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Brazil; Postgraduate Program in Endocrinology, School of Medicine, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, Ilha do Governador, Cidade Universitária, UFRJ, RJ, Brazil
| | - Genoa R Warner
- Department of Chemistry and Environmental Science, New Jersey Institute of Technology, USA
| | - Jones B Graceli
- Department of Morphology, Federal University of Espírito Santo, Vitória, Brazil.
| |
Collapse
|
3
|
Rodrigues-Pereira P, Andrade MN, Santos-Silva AP, Teixeira MP, Soares P, Graceli JB, de Carvalho DP, Dias GRM, Ferreira ACF, Miranda-Alves L. Subacute and low-dose tributyltin exposure disturbs the mammalian hypothalamus-pituitary-thyroid axis in a sex-dependent manner. Comp Biochem Physiol C Toxicol Pharmacol 2022; 254:109279. [PMID: 35077874 DOI: 10.1016/j.cbpc.2022.109279] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 01/18/2022] [Accepted: 01/19/2022] [Indexed: 11/03/2022]
Abstract
Tributyltin (TBT) is an endocrine disruptor chemical (EDC) capable of altering the proper function of the hypothalamus-pituitary thyroid (HPT) axis. This study aimed to evaluate the subacute effects of TBT on the HPT axis of male and female rats. A dose of 100 ng/kg/day TBT was used in both sexes over a 15-day period, and the morphophysiology and gene expression of the HPT axis were assessed. TBT exposure increased the body weight in both sexes, while food efficiency increased - only in male rats. It was also possible to note alterations in the thyroid, with the presence of a stratified epithelium, cystic degeneration, and increased interstitial collagen deposition. A reduction in T3 and T4 levels was only observed in TBT male rats. A reduction in TSH levels was observed in TBT female rats. Evaluating mRNA expression, we observed a decrease in hepatic D1 and TRH mRNA levels in TBT female rats. An increase in D2 mRNA expression in the hypothalamus was observed in TBT male rats. Additionally, no significant changes in TRH or hepatic D1 mRNA expression in TBT male rats or in hypothalamic D1 and D2 mRNA expression in TBT female rats were observed. Thus, we can conclude that TBT has different toxicological effects on male and female rats by altering thyroid gland morphophysiology, leading to abnormal HPT axis function, and even at subacute and low doses, it may be involved in complex endocrine and metabolic disorders.
Collapse
Affiliation(s)
- Paula Rodrigues-Pereira
- Laboratório de Endocrinologia Experimental-LEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil
| | - Marcelle Novaes Andrade
- Laboratório de Endocrinologia Experimental-LEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
| | - Ana Paula Santos-Silva
- Laboratório de Endocrinologia Experimental-LEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Núcleo Interdisciplinar NUMPEX, Campus Duque de Caxias, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Mariana Pires Teixeira
- Laboratório de Endocrinologia Experimental-LEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil
| | - Paula Soares
- Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal; Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal; Departamento de Patologia, Faculdade de Medicina da Universidade do Porto (FMUP), Porto, Portugal
| | - Jones Bernardes Graceli
- Laboratório de Toxicologia e Endocrinologia, Departamento de Morfologia, Universidade Federal do Espírito Santo, Brazil
| | - Denise Pires de Carvalho
- Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil
| | - Glaecir Roseni Mundstock Dias
- Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil
| | - Andrea Claudia Freitas Ferreira
- Núcleo Interdisciplinar NUMPEX, Campus Duque de Caxias, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil
| | - Leandro Miranda-Alves
- Laboratório de Endocrinologia Experimental-LEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil.
| |
Collapse
|
4
|
Huang X, Ma T, Chen X. Tributyltin inhibits development of pubertal Leydig cells in rats. Reprod Toxicol 2022; 111:49-58. [DOI: 10.1016/j.reprotox.2022.04.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 03/05/2022] [Accepted: 04/11/2022] [Indexed: 11/27/2022]
|
5
|
Hypothalamic Expression of Neuropeptide Y (NPY) and Pro-OpioMelanoCortin (POMC) in Adult Male Mice Is Affected by Chronic Exposure to Endocrine Disruptors. Metabolites 2021; 11:metabo11060368. [PMID: 34207679 PMCID: PMC8228876 DOI: 10.3390/metabo11060368] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2021] [Revised: 06/04/2021] [Accepted: 06/06/2021] [Indexed: 02/07/2023] Open
Abstract
In the arcuate nucleus, neuropeptide Y (NPY) neurons, increase food intake and decrease energy expenditure, and control the activity of pro-opiomelanocortin (POMC) neurons, that decrease food intake and increase energy expenditure. Both systems project to other hypothalamic nuclei such as the paraventricular and dorsomedial hypothalamic nuclei. Endocrine disrupting chemicals (EDCs) are environmental contaminants that alter the endocrine system causing adverse health effects in an intact organism or its progeny. We investigated the effects of long-term exposure to some EDCs on the hypothalamic NPY and POMC systems of adult male mice that had been previously demonstrated to be a target of some of these EDCs after short-term exposure. Animals were chronically fed for four months with a phytoestrogen-free diet containing two different concentrations of bisphenol A, diethylstilbestrol, tributyltin, or E2. At the end, brains were processed for NPY and POMC immunohistochemistry and quantitatively analyzed. In the arcuate and dorsomedial nuclei, both NPY and POMC immunoreactivity showed a statistically significant decrease. In the paraventricular nucleus, only the NPY system was affected, while the POMC system was not affected. Finally, in the VMH the NPY system was affected whereas no POMC immunoreactive material was observed. These results indicate that adult exposure to different EDCs may alter the hypothalamic circuits that control food intake and energy metabolism.
Collapse
|
6
|
Ahmed MG, Ibrahim MED, El Sayed HR, Ahmed SM. Short term chronic toxicity of tributyltin on the testes of adult albino rats and the possible protective role of omega-3. Hum Exp Toxicol 2020; 40:214-230. [PMID: 32783468 DOI: 10.1177/0960327120947451] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The declining rate of male fertility is a growing concern. Tributyltin (TBT) is a well-known endocrine disruptor (ED), that induces imposex in female gastropods and is widely used in various industrial applications. The aim of this study was to evaluate the toxic effects of TBT on the testes of adult albino rats and the possible role of omega-3. Forty two adult male albino rats were divided into five groups; control group (Group I) and four experimental groups: omega-3 treated group, TBT treated group, TBT & omega-3 treated group and follow up group. At the end of the study, the rats were subjected to biochemical, histological, immunohistochemical staining for Ki-67 and seminal examinations. Our results clarfied that TBT induced a significant decrease in testosterone, FSH, LH and serum glutathione peroxidase levels and a significant increase in the serum Malondialdehyde as compared to the control group. Tributyltin induced disorganization and shrinkage of seminiferous tubules, apoptosis, cellular damage and marked reduction in the germinal epithelium. A significant decrease in the cell proliferation and arrested spermatogenesis were also detected. Seminal analysis of TBT group showed a significant affection of all parameters as compared to other groups. Omega-3 ameliorated all of these hazardous effects. Follow up group still showed toxic effects. In conclusion, TBT has a toxic effect on the testis. Increased testicular oxidative stress, cellular damage and arrest of spermatogenesis with attenuation in antioxidant defenses are all contributing factors. Omega-3 can protect against TBT induced reproductive toxicity.
Collapse
Affiliation(s)
- Marwa G Ahmed
- Department of Forensic Medicine and Clinical Toxicology, 68865Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Mona El-Demerdash Ibrahim
- Department of Forensic Medicine and Clinical Toxicology, 68865Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Hoda R El Sayed
- Department of Forensic Medicine and Clinical Toxicology, 68865Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Samah M Ahmed
- Department of Histology & Cell Biology, 68865Faculty of Medicine, Zagazig University, Zagazig, Egypt
| |
Collapse
|
7
|
Yao W, Wei X, Guo H, Cheng D, Li H, Sun L, Wang S, Guo D, Yang Y, Si J. Tributyltin reduces bone mineral density by reprograming bone marrow mesenchymal stem cells in rat. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2020; 73:103271. [PMID: 31627035 DOI: 10.1016/j.etap.2019.103271] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/11/2019] [Revised: 10/03/2019] [Accepted: 10/04/2019] [Indexed: 06/10/2023]
Abstract
Tributyltin (TBT), a proven endocrine disrupter, was widely used in industry and agriculture. Previous research showed that TBT could alter the balance between osteogenesis and adipogenesis, which may have significant consequences for bone health. Herein, we exposed male rats to TBT chloride (TBTCl) to evaluate the deleterious effects of TBT on bone. Exposure to 50 μg kg-1 TBT resulted in a significant decrease in bone mineral density (BMD) at the femur diaphysis region in the rat. A dose-dependent increase in lipid accumulation and adipocyte number was observed in the bone marrow (BM) of the femur. Meanwhile, TBTCl treatment significantly enhanced the expression of PPARγ and attenuated the expression of Runx2 and β-catenin in BM. In addition, serum ALP activity of TBT-exposed rats also showed a dose-dependent decrease. These results suggest that TBT could reduce BMD via inhibition of the Wnt/β-catenin pathway and skew the adipo-osteogenic balance in the BM of rats.
Collapse
Affiliation(s)
- Wenhuan Yao
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Toxicology, Shandong Center for Disease Control and Prevention, Jinan, China
| | - Xinglong Wei
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Hao Guo
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Dong Cheng
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Toxicology, Shandong Center for Disease Control and Prevention, Jinan, China
| | - Hui Li
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Toxicology, Shandong Center for Disease Control and Prevention, Jinan, China
| | - Limin Sun
- Orthopedics Department, Shandong Provincial Third Hospital, Jinan, China
| | - Shu'e Wang
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Dongmei Guo
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Yanli Yang
- Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Jiliang Si
- Institute of Preventive Medicine, Shandong University, Jinan, China; Department of Environmental Health, School of Public Health, Shandong University, Jinan, China.
| |
Collapse
|
8
|
Andrade MN, Santos-Silva AP, Rodrigues-Pereira P, Paiva-Melo FD, de Lima Junior NC, Teixeira MP, Soares P, Dias GRM, Graceli JB, de Carvalho DP, Ferreira ACF, Miranda-Alves L. The environmental contaminant tributyltin leads to abnormalities in different levels of the hypothalamus-pituitary-thyroid axis in female rats. ENVIRONMENTAL POLLUTION (BARKING, ESSEX : 1987) 2018; 241:636-645. [PMID: 29902746 DOI: 10.1016/j.envpol.2018.06.006] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/30/2017] [Revised: 06/01/2018] [Accepted: 06/02/2018] [Indexed: 06/08/2023]
Abstract
Tributyltin is a biocide used in nautical paints, aiming to reduce fouling of barnacles in ships. Despite the fact that many effects of TBT on marine species are known, studies in mammals have been limited, especially those evaluating its effect on the function of the hypothalamus-pituitary-thyroid (HPT) axis. The aim of this study was to investigate the effects of subchronic exposure to TBT on the HPT axis in female rats. Female Wistar rats received vehicle, TBT 200 ng kg-1 BW d-1 or 1000 ng kg-1 BW d-1 orally by gavage for 40 d. Hypothalamus, pituitary, thyroid, liver and blood samples were collected. TBT200 and TBT1000 thyroids showed vacuolated follicular cells, with follicular hypertrophy and hyperplasia. An increase in epithelial height and a decrease in the thyroid follicle and colloid area were observed in TBT1000 rats. Moreover, an increase in the epithelium/colloid area ratio was observed in both TBT groups. Lower TRH mRNA expression was observed in the hypothalami of TBT200 and TBT1000 rats. An increase in Dio1 mRNA levels was observed in the hypothalamus and thyroid in TBT1000 rats only. TSH serum levels were increased in TBT200 rats. In TBT1000 rats, there was a decrease in total T4 serum levels compared to control rats, whereas T3 serum levels did not show significant alterations. We conclude that TBT exposure can promote critical abnormalities in the HPT axis, including changes in TRH mRNA expression and serum TSH and T4 levels, in addition to affecting thyroid morphology. These findings demonstrate that TBT disrupts the HPT axis. Additionally, the changes found in thyroid hormones suggest that TBT may interfere with the peripheral metabolism of these hormones, an idea corroborated by the observed changes in Dio1 mRNA levels. Therefore, TBT exposition might interfere not only with the thyroid axis but also with thyroid hormone metabolism.
Collapse
Affiliation(s)
- Marcelle Novaes Andrade
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
| | - Ana Paula Santos-Silva
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil
| | - Paula Rodrigues-Pereira
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil
| | - Francisca Diana Paiva-Melo
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil
| | - Niedson Correa de Lima Junior
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil
| | - Mariana Pires Teixeira
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Patologia, Universidade Federal Fluminense, Brazil
| | - Paula Soares
- Institute for Research and Innovation in Health, University of Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) - Cancer Biology, Porto, Portugal; Medical Faculty, University of Porto, Porto, Portugal; Department of Pathology, Medical Faculty of Porto University, Porto, Portugal
| | - Glaecir Roseni Munstock Dias
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil
| | - Jones Bernardes Graceli
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Endocrinologia e Toxicologia Celular, Departamento de Morfologia, Universidade Federal do Espírito Santo, Brazil
| | - Denise Pires de Carvalho
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil
| | - Andrea Claudia Freitas Ferreira
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Polo de Xerém/NUMPEX, Universidade Federal do Rio de Janeiro, Brazil
| | - Leandro Miranda-Alves
- Grupo de Pesquisa, Desenvolvimento e Inovação em Endocrinologia Experimental-GPDIEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil; Programa de Pós-graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil.
| |
Collapse
|
9
|
Veiga-Lopez A, Pu Y, Gingrich J, Padmanabhan V. Obesogenic Endocrine Disrupting Chemicals: Identifying Knowledge Gaps. Trends Endocrinol Metab 2018; 29:607-625. [PMID: 30017741 PMCID: PMC6098722 DOI: 10.1016/j.tem.2018.06.003] [Citation(s) in RCA: 70] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Revised: 06/11/2018] [Accepted: 06/14/2018] [Indexed: 02/07/2023]
Abstract
Endocrine disrupting chemicals (EDCs) are compounds that are part of everyday consumer products and industrial manufacturing processes. EDCs can interfere with the endocrine system, including the adipose tissue. Accumulating evidence from epidemiological, animal, and in vitro studies demonstrates that EDCs can alter body weight, adipose tissue expansion, circulating lipid profile, and adipogenesis, with some resulting in transgenerational effects. These outcomes appear to be mediated through multiple mechanisms, from nuclear receptor binding to epigenetic modifications. A better understanding of the signaling pathways via which these EDCs contribute to an obesogenic phenotype, the interaction amongst complex mixtures of obesogenic EDCs, and the risks they pose relative to the obesity epidemic are still needed for risk assessment and development of prevention strategies.
Collapse
Affiliation(s)
- Almudena Veiga-Lopez
- Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824, USA.
| | - Yong Pu
- Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824, USA
| | - Jeremy Gingrich
- Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824, USA; Department of Pharmacology and Toxicology, College of Natural Sciences, Michigan State University, East Lansing, MI 48824, USA
| | - Vasantha Padmanabhan
- Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109, USA.
| |
Collapse
|
10
|
Farinetti A, Marraudino M, Ponti G, Panzica G, Gotti S. Chronic treatment with tributyltin induces sexually dimorphic alterations in the hypothalamic POMC system of adult mice. Cell Tissue Res 2018; 374:587-594. [PMID: 30078105 DOI: 10.1007/s00441-018-2896-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2017] [Accepted: 07/20/2018] [Indexed: 12/11/2022]
Abstract
Tributyltin (TBT), an antifouling agent found in boat paints, is a common contaminant of marine and freshwater ecosystems. It is rapidly absorbed by organic materials and accumulated in many aquatic animals. Human exposure may depend on ingestion of contaminated food or by indirect exposure from household items containing organotin compounds. TBT is defined as an endocrine disruptor compound (EDC) because it binds to androgen receptors. Moreover, it is also included on the list of metabolic disruptors. The brain is a known target of TBT and this compound interferes with the orexigenic system, inducing a strong decrease in NPY expression in the hypothalamus. In the present experiment, we investigated the effect of a chronic treatment with TBT on the mouse anorexigenic system in both sexes, to look at the pro-opiomelanocortin (POMC) expression in the paraventricular (PVN), dorsomedial (DMN), ventromedial (VMN), and arcuate (ARC) hypothalamic nuclei. The results show a sexually dimorphic effect of TBT on both systems. TBT induced a significant decrease of POMC-positive structures only in female mice in DMN, ARC, and in PVN for both sexes. Apparently, these results show that TBT may interfere with the anorexigenic system in hypothalamic areas involved in the control of food intake, by inhibiting POMC in a sexually dimorphic way. In conclusion, in addition to having a direct effect on fat tissue, the effects of TBT as metabolic disruptor, may be due to gender-specific actions on both orexigenic and anorexigenic hypothalamic systems.
Collapse
Affiliation(s)
- Alice Farinetti
- Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.,Laboratorio di Neuroendocrinologia, NICO-Neuroscience Institute Cavalieri Ottolenghi, Regione Gonzole, 10, Orbassano, Turin, 10043, Italy
| | - Marilena Marraudino
- Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.,Laboratorio di Neuroendocrinologia, NICO-Neuroscience Institute Cavalieri Ottolenghi, Regione Gonzole, 10, Orbassano, Turin, 10043, Italy
| | - Giovanna Ponti
- Laboratorio di Neuroendocrinologia, NICO-Neuroscience Institute Cavalieri Ottolenghi, Regione Gonzole, 10, Orbassano, Turin, 10043, Italy.,Department of Veterinary Sciences, University of Turin, Grugliasco, Turin, Italy
| | - GianCarlo Panzica
- Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.,Laboratorio di Neuroendocrinologia, NICO-Neuroscience Institute Cavalieri Ottolenghi, Regione Gonzole, 10, Orbassano, Turin, 10043, Italy
| | - Stefano Gotti
- Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy. .,Laboratorio di Neuroendocrinologia, NICO-Neuroscience Institute Cavalieri Ottolenghi, Regione Gonzole, 10, Orbassano, Turin, 10043, Italy.
| |
Collapse
|
11
|
Yan H, Guo H, Cheng D, Kou R, Zhang C, Si J. Tributyltin reduces the levels of serum adiponectin and activity of AKT and induces metabolic syndrome in male mice. ENVIRONMENTAL TOXICOLOGY 2018; 33:752-758. [PMID: 29675927 DOI: 10.1002/tox.22562] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2017] [Revised: 03/28/2018] [Accepted: 04/01/2018] [Indexed: 06/08/2023]
Abstract
Tributyltin (TBT), a proven environmental obesogen, functions as a nanomolar agonist of the peroxisome proliferator activated receptor-γ (PPARγ). However, the adverse effects of TBT on metabolism are incompletely understood. In this study, male ICR mice were administered TBT (5 and 50 μg·kg-1 ) by an intraperitoneal injection once every 3 days for 30 days from 28 days of age and bred for another 30 days after the last administration of TBT. We analyzed the effects of these exposures on the fat depot weights, serum lipid profile, serum leptin and adiponectin, hepatic lipid accumulation, and activity of AKT in the liver and skeletal muscle isolated from mice 8 mins after receiving an insulin injection. Pubertal exposure to TBTCl resulted in a higher body weight, increased epididymal and liver fat accumulation, hyperlipidemia, an elevated low-density lipoprotein/high-density lipoprotein ratio, serum adiponectin deficiency, worse glucose tolerance, and lower insulin-dependent AKT phosphorylation in the liver and muscle in mice. These results showed that TBT exposure induced peripheral insulin resistance and metabolic syndrome in mice.
Collapse
Affiliation(s)
- Haotian Yan
- Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Hao Guo
- Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Dong Cheng
- Department of Toxicology, Shandong Center for Disease Control and Prevention, Jinan, Shandong, 250014, China
| | - Ruirui Kou
- Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Cuili Zhang
- Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | - Jiliang Si
- Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| |
Collapse
|
12
|
Lagadic L, Katsiadaki I, Biever R, Guiney PD, Karouna-Renier N, Schwarz T, Meador JP. Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound. REVIEWS OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY 2018; 245:65-127. [PMID: 29119384 DOI: 10.1007/398_2017_8] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Tributyltin (TBT) has been recognized as an endocrine disrupting chemical (EDC) for several decades. However, only in the last decade, was its primary endocrine mechanism of action (MeOA) elucidated-interactions with the nuclear retinoid-X receptor (RXR), peroxisome proliferator-activated receptor γ (PPARγ), and their heterodimers. This molecular initiating event (MIE) alters a range of reproductive, developmental, and metabolic pathways at the organism level. It is noteworthy that a variety of MeOAs have been proposed over the years for the observed endocrine-type effects of TBT; however, convincing data for the MIE was provided only recently and now several researchers have confirmed and refined the information on this MeOA. One of the most important lessons learned from years of research on TBT concerns apparent species sensitivity. Several aspects such as the rates of uptake and elimination, chemical potency, and metabolic capacity are all important for identifying the most sensitive species for a given chemical, including EDCs. For TBT, much of this was discovered by trial and error, hence important relationships and important sensitive taxa were not identified until several decades after its introduction to the environment. As recognized for many years, TBT-induced responses are known to occur at very low concentrations for molluscs, a fact that has more recently also been observed in fish species. This review explores the MeOA and effects of TBT in different species (aquatic molluscs and other invertebrates, fish, amphibians, birds, and mammals) according to the OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment (CFEDTA). The information gathered on biological effects that are relevant for populations of aquatic animals was used to construct Species Sensitivity Distributions (SSDs) based on No Observed Effect Concentrations (NOECs) and Lowest Observed Effect Concentrations (LOECs). Fish appear at the lower end of these distributions, showing that they are as sensitive as molluscs, and for some species, even more sensitive. Concentrations in the range of 1 ng/L for water exposure (10 ng/g for whole-body burden) have been shown to elicit endocrine-type responses, whereas mortality occurs at water concentrations ten times higher. Current screening and assessment methodologies as compiled in the OECD CFEDTA are able to identify TBT as a potent endocrine disruptor with a high environmental risk for the original use pattern. If those approaches had been available when TBT was introduced to the market, it is likely that its use would have been regulated sooner, thus avoiding the detrimental effects on marine gastropod populations and communities as documented over several decades.
Collapse
Affiliation(s)
- Laurent Lagadic
- Bayer AG, Research and Development, Crop Science Division, Environmental Safety, Alfred-Nobel-Straße 50, Monheim am Rhein, 40789, Germany.
| | - Ioanna Katsiadaki
- Centre for Environment, Fisheries and Aquaculture Science, Barrack Road, The Nothe, Weymouth, Dorset, DT4 8UB, UK
| | - Ron Biever
- Smithers Viscient, 790 Main Street, Wareham, MA, 02571, USA
| | - Patrick D Guiney
- University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI, 53705-2222, USA
| | - Natalie Karouna-Renier
- USGS Patuxent Wildlife Research Center, BARC East Bldg 308, 10300 Baltimore Avenue, Beltsville, MD, 20705, USA
| | - Tamar Schwarz
- Centre for Environment, Fisheries and Aquaculture Science, Barrack Road, The Nothe, Weymouth, Dorset, DT4 8UB, UK
| | - James P Meador
- Environmental and Fisheries Sciences Division, Northwest Fisheries Science Center, National Marine Fisheries Service, National Oceanic and Atmospheric Administration, Seattle, WA, 98112, USA
| |
Collapse
|
13
|
Narciso L, Catone T, Aquilina G, Attias L, De Angelis I, Iuliano MG, Tassinari R, Mantovani A, Maranghi F. The juvenile toxicity study as a tool for a science-based risk assessment in the children population group. Reprod Toxicol 2017; 72:136-141. [DOI: 10.1016/j.reprotox.2017.06.188] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2017] [Revised: 06/20/2017] [Accepted: 06/30/2017] [Indexed: 02/08/2023]
|
14
|
Hart RJ, Doherty DA, Keelan JA, McLachlan R, Skakkebaek NE, Norman RJ, Dickinson JE, Pennell CE, Newnham JP, Hickey M, Handelsman DJ. Early Life Events Predict Adult Testicular Function; Data Derived From the Western Australian (Raine) Birth Cohort. J Clin Endocrinol Metab 2016; 101:3333-44. [PMID: 27340882 DOI: 10.1210/jc.2016-1646] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CONTEXT The impact of early life events on testicular function in adulthood is not well understood. OBJECTIVE To study the early influences of fetal growth, exposures to cigarette smoke in utero and cord blood estrogens, and the influences of growth and adiposity in childhood through adolescence; on testicular function in adulthood. DESIGN Male members of the Western Australian Pregnancy Cohort (Raine) were contacted at 20-22 years of age. Of 913 contacted, 423 (56%) agreed to participate; 404 underwent a testicular ultrasound, 365 provided a semen sample, and reproductive hormones were measured (384). Fetal growth measurements (n = 137), umbilical cord estrogen concentrations (n = 128), cord testosterone (T) (n = 125), and child-adulthood growth charts (n = 395) were available. RESULTS Median sperm output for the 18.6% of men exposed in utero to smoking was lower than nonexposed (82.4 × 10(6) vs 123.1 × 10(6); P = .029). Sperm output in adulthood was inversely correlated with cord serum estradiol (P = .019) and estrone (P = .018). The sperm output of men whose cord blood estradiol and estrone were less than 50th percentile vs more than 50th percentile was 191.1 × 10(6) vs 100.5 × 10(6) (P = .002) and 190.0 × 10(6) vs 106.0 × 10(6) (P = .012), respectively. Men with favorable fetal growth patterns in utero were less likely to have total motile sperm counts within the lowest quartile (P = .011), and men born prematurely had reduced serum T levels in adulthood (13.4 vs 16.6nmol/L, P = .024). Consistent height above the 50th percentile for age through childhood was associated with larger adult mean testicular volume (P < .001). Optimal body mass index trajectory through childhood and adolescence was associated with larger testicular volume (P = .009) and higher serum inhibin B (P = .010) and T (P = .003) in adulthood. CONCLUSIONS Exposures to maternal smoking and higher cord blood estrogens at delivery were associated with a reduced sperm output in adulthood. Optimal adult testicular function depends on being born at or above average weight, and maintaining optimal growth and adiposity into adulthood.
Collapse
Affiliation(s)
- Roger J Hart
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Dorota A Doherty
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Jeffrey A Keelan
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Rob McLachlan
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Niels E Skakkebaek
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Robert J Norman
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Jan E Dickinson
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Craig E Pennell
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - John P Newnham
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - Martha Hickey
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| | - David J Handelsman
- School of Women's and Infants' Health (R.J.H., D.A.D., J.A.K., J.E.D., C.E.P., J.P.N.), The University of Western Australia, Perth, Western Australia 6008, Australia; Fertility Specialists of Western Australia (R.J.H.), Bethesda Hospital, Claremont, Western Australia 6010, Australia; Women and Infants Research Foundation (D.A.D., J.A.K., C.E.P., J.P.N.), King Edward Memorial Hospital, Perth, Western Australia 6008, Australia; Centre for Endocrinology and Metabolism (R.M.), Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia; Monash University (R.M.), Clayton, Victoria 3168, Australia; University Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Department of Growth and Reproduction, 2100 Copenhagen, Denmark; Robinson Institute (R.J.N.), University of Adelaide, Adelaide, South Australia 5000, Australia; Department of Obstetrics and Gynaecology (M.H.), The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria 3052, Australia; and ANZAC Research Institute (D.J.H.), University of Sydney, Concord Hospital, Sydney, New South Wales 2139, Australia
| |
Collapse
|
15
|
Lyssimachou A, Santos JG, André A, Soares J, Lima D, Guimarães L, Almeida CMR, Teixeira C, Castro LFC, Santos MM. The Mammalian "Obesogen" Tributyltin Targets Hepatic Triglyceride Accumulation and the Transcriptional Regulation of Lipid Metabolism in the Liver and Brain of Zebrafish. PLoS One 2015; 10:e0143911. [PMID: 26633012 PMCID: PMC4669123 DOI: 10.1371/journal.pone.0143911] [Citation(s) in RCA: 73] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2014] [Accepted: 11/11/2015] [Indexed: 12/18/2022] Open
Abstract
Recent findings indicate that different Endocrine Disrupting Chemicals (EDCs) interfere with lipid metabolic pathways in mammals and promote fat accumulation, a previously unknown site of action for these compounds. The antifoulant and environmental pollutant tributyltin (TBT), which causes imposex in gastropod snails, induces an “obesogenic” phenotype in mammals, through the activation of the nuclear receptors retinoid X receptor (RXR) and peroxisome proliferator-activated receptor gamma (PPARγ). In teleosts, the effects of TBT on the lipid metabolism are poorly understood, particularly following exposure to low, environmental concentrations. In this context, the present work shows that exposure of zebrafish to 10 and 50 ng/L of TBT (as Sn) from pre-hatch to 9 months of age alters the body weight, condition factor, hepatosomatic index and hepatic triglycerides in a gender and dose related manner. Furthermore, TBT modulated the transcription of key lipid regulating factors and enzymes involved in adipogenesis, lipogenesis, glucocorticoid metabolism, growth and development in the brain and liver of exposed fish, revealing sexual dimorphic effects in the latter. Overall, the present study shows that the model mammalian obesogen TBT interferes with triglyceride accumulation and the transcriptional regulation of lipid metabolism in zebrafish and indentifies the brain lipogenic transcription profile of fish as a new target of this compound.
Collapse
Affiliation(s)
- Angeliki Lyssimachou
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
- * E-mail: (AL); (LFCC); (MMS)
| | - Joana G. Santos
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
| | - Ana André
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
| | - Joana Soares
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
| | - Daniela Lima
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
| | - Laura Guimarães
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
| | - C. Marisa R. Almeida
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
| | - Catarina Teixeira
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
| | - L. Filipe C. Castro
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
- * E-mail: (AL); (LFCC); (MMS)
| | - Miguel M. Santos
- CIMAR/CIIMAR-AL, Interdisciplinary Centre of Marine and Environmental Research, Rua dos Bragas 289, 4050–123, Porto, Portugal
- FCUP–Department of Biology, Faculty of Sciences, University of Porto, Porto, Portugal
- * E-mail: (AL); (LFCC); (MMS)
| |
Collapse
|
16
|
Regnier SM, El-Hashani E, Kamau W, Zhang X, Massad NL, Sargis RM. Tributyltin differentially promotes development of a phenotypically distinct adipocyte. Obesity (Silver Spring) 2015; 23:1864-71. [PMID: 26243053 PMCID: PMC4551608 DOI: 10.1002/oby.21174] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Accepted: 05/07/2015] [Indexed: 11/19/2022]
Abstract
OBJECTIVE Environmental endocrine disrupting chemicals (EDCs) are increasingly implicated in the pathogenesis of obesity. Evidence implicates various EDCs as being proadipogenic, including tributyltin (TBT), which activates the peroxisome proliferator activated receptor-γ (PPARγ). However, the conditions required for TBT-induced adipogenesis and its functional consequences are incompletely known. METHODS The costimulatory conditions necessary for preadipocyte-to-adipocyte differentiation were compared between TBT and the pharmacological PPARγ agonist troglitazone (Trog) in the 3T3-L1 cell line; basal and insulin-stimulated glucose uptake were assessed using radiolabeled 2-deoxyglucose. RESULTS TBT enhanced expression of the adipocyte marker C/EBPα with coexposure to either isobutylmethylxanthine or insulin in the absence of other adipogenic stimuli. Examination of several adipocyte-specific proteins revealed that TBT and Trog differentially affected protein expression despite comparable PPARγ stimulation. In particular, TBT reduced adiponectin expression upon maximal adipogenic stimulation. Under submaximal stimulation, TBT and Trog differentially promoted adipocyte-specific gene expression despite similar lipid accumulation. Moreover, TBT attenuated Trog-induced adipocyte gene expression under conditions of cotreatment. Finally, TBT-induced adipocytes exhibited altered glucose metabolism, with increased basal glucose uptake. CONCLUSIONS TBT-induced adipocytes are functionally distinct from those generated by a pharmacological PPARγ agonist, suggesting that obesogen-induced adipogenesis may generate dysfunctional adipocytes with the capacity to deleteriously affect global energy homeostasis.
Collapse
Affiliation(s)
- Shane M. Regnier
- Committee on Molecular Metabolism and Nutrition, University of Chicago, Chicago, IL
- Pritzker School of Medicine, University of Chicago, Chicago, IL
| | - Essam El-Hashani
- Kovler Diabetes Center, University of Chicago, Chicago, IL
- Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL
| | - Wakanene Kamau
- Kovler Diabetes Center, University of Chicago, Chicago, IL
- Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL
| | - Xiaojie Zhang
- Kovler Diabetes Center, University of Chicago, Chicago, IL
- Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL
| | - Nicole L. Massad
- Kovler Diabetes Center, University of Chicago, Chicago, IL
- Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL
| | - Robert M. Sargis
- Committee on Molecular Metabolism and Nutrition, University of Chicago, Chicago, IL
- Pritzker School of Medicine, University of Chicago, Chicago, IL
- Kovler Diabetes Center, University of Chicago, Chicago, IL
- Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL
- Corresponding Author: Robert M. Sargis, MD, PhD, University of Chicago, Section of Endocrinology, Diabetes and Metabolism, 900 E. 57 ST, KCBD 8120, Chicago, IL 60637, Phone: 773-834-1915, Fax: 773-834-0851,
| |
Collapse
|
17
|
Si J, Li P, Xin Q, Li X, An L, Li J. Perinatal exposure to low doses of tributyltin chloride reduces sperm count and quality in mice. ENVIRONMENTAL TOXICOLOGY 2015; 30:44-52. [PMID: 23913619 DOI: 10.1002/tox.21892] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2013] [Revised: 06/20/2013] [Accepted: 06/26/2013] [Indexed: 06/02/2023]
Abstract
Exposure to endocrine disruptors (EDs) during early development might lead to adverse health outcomes later in life. Tributyltin (TBT), a proven ED, is widely used in consumer goods and industrial products. Herein we demonstrate the effects of low doses of tributyltin chloride (TBTCl) on reproduction of male KM mice. Pregnant mice were administered by gavage with 0, 1, 10, or 100 μg TBTCl/kg body weight/day from day 6 of pregnancy through the period of lactation. TBTCl dramatically decreased sperm counts and motility on postnatal days (PNDs) 49 and 152. Meanwhile, a significant increase in sperm abnormality was observed in exposed mice on PND 49, but comparable to that in the control on PND 152. The histopathological analysis of testes of treated animals showed a dose-dependent increase in sloughing of germ cells in seminiferous tubules. Mice treated with 10 μg TBTCl/kg exhibited decreased intratesticular 17β-estradiol (E2) levels on PND 49, and then followed by an obvious recovery on PND 152. While, no significant differences in serum E2, testosterone (T) levels and intratesticular T levels were detectable between control and TBTCl-exposed offspring at the sacrifice. These results suggest that perinatal TBTCl exposure is implicated in causing long lasting alterations in male reproductive system and these changes may persist far into adulthood.
Collapse
Affiliation(s)
- Jiliang Si
- Department of Environmental Health, School of Public Health, Shandong University, Jinan, China
| | | | | | | | | | | |
Collapse
|
18
|
Lima D, Castro LFC, Coelho I, Lacerda R, Gesto M, Soares J, André A, Capela R, Torres T, Carvalho AP, Santos MM. Effects of Tributyltin and Other Retinoid Receptor Agonists in Reproductive-Related Endpoints in the Zebrafish (Danio rerio). JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH. PART A 2015; 78:747-60. [PMID: 26090559 DOI: 10.1080/15287394.2015.1028301] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Both field and experimental data examined the influence of exposure to environmental contaminant tributyltin (TBT) on marine organisms. Although most attention focused on the imposex phenomenon in gastropods, adverse effects were also observed in other taxonomic groups. It has been shown that imposex induction involves modulation of retinoid signaling in gastropods. Whether TBT influences similar pathways in fish is yet to be addressed. In this study, larvae of the model teleost Danio rerio were exposed to natural retinoids, all-trans-retinoic acid, 9-cis-retinoic acid, and all-trans-retinol, as well as to the RXR synthetic pan-agonist methoprene acid (MA) and to TBT. Larvae were exposed to TBT from 5 days post fertilization (dpf) to adulthood, and reproductive capacity was assessed and correlated with mode of action. TBT significantly decreased fecundity at environmentally relevant levels at 1 μg TBT Sn/g in diet. Interestingly, in contrast to previous reports, TBT altered zebrafish sex ratio toward females, whereas MA exposure biased sex toward males. Since fecundity was significantly altered in the TBT-exposed group with up to 62% decrease, the potentially affected pathways were investigated. Significant downregulation was observed in brain mRNA levels of aromatase b (CYP19a1b) in females and peroxisome proliferator activated receptor gamma (PPARg) in both males and females, suggesting an involvement of these pathways in reproductive impairment associated with TBT.
Collapse
Affiliation(s)
- Daniela Lima
- a Interdisciplinary Centre for Marine and Environmental Research (CIIMAR), CIMAR Associate Laboratory , University of Porto Porto , Portugal
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
The obesogen hypothesis postulates the role of environmental chemical pollutants that disrupt homeostatic controls and adaptive mechanisms to promote adipose-dependent weight gain leading to obesity and metabolic syndrome complications. One of the most direct molecular mechanisms for coupling environmental chemical exposures to perturbed physiology invokes pollutants mimicking endogenous endocrine hormones or bioactive dietary signaling metabolites that serve as nuclear receptor ligands. The organotin pollutant tributyltin can exert toxicity through multiple mechanisms but most recently has been shown to bind, activate, and mediate RXR-PPARγ transcriptional regulation central to lipid metabolism and adipocyte biology. Data in support of long-term obesogenic effects on whole body adipose tissue are also reported. Organotins represent an important model test system for evaluating the impact and epidemiological significance of chemical insults as contributing factors for obesity and human metabolic health.
Collapse
Affiliation(s)
- Felix Grün
- The Center for Complex Biological Systems, University of California Irvine, Irvine, California, USA.
| |
Collapse
|
20
|
Si J, Han X, Zhang F, Xin Q, An L, Li G, Li C. Perinatal exposure to low doses of tributyltin chloride advances puberty and affects patterns of estrous cyclicity in female mice. ENVIRONMENTAL TOXICOLOGY 2012; 27:662-670. [PMID: 22362710 DOI: 10.1002/tox.21756] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/26/2011] [Accepted: 12/03/2011] [Indexed: 05/31/2023]
Abstract
Tributyltin (TBT), a proven endocrine-disrupting chemical, is well known to induce imposex in female gastropods. Herein we demonstrate the effects of low doses of tributyltin chloride (TBTCl) on the female offspring of KM mice. Pregnant mice were administered by gavage with 0, 1, 10, or 100 μg TBTCl/kg body weight/day from day 6 of pregnancy through the period of lactation. TBTCl dramatically advanced the age of onset of vaginal opening (VO) and first vaginal estrus, and reduced body weights at VO and first estrus. Furthermore, perinatal treatment with TBTCl significantly reduced the number of days between VO and first estrus. In addition, female offspring from dams exposed to 10 and 100 μg kg(-1) TBTCl exhibited altered patterns of estrous cyclicity in adulthood. In conclusion, perinatal exposure to low doses TBTCl result in early puberty and impaired estrous cyclicity in female mice, which suggest that TBTCl might act as an estrogen agonist or/and a disruptor on hypothalamic-pituitary function in the present study.
Collapse
Affiliation(s)
- Jiliang Si
- School of Public Health, Shandong University, Jinan, People's Republic of China
| | | | | | | | | | | | | |
Collapse
|
21
|
Si J, Li J, Zhang F, Li G, Xin Q, Dai B. Effects of perinatal exposure to low doses of tributyltin chloride on pregnancy outcome and postnatal development in mouse offspring. ENVIRONMENTAL TOXICOLOGY 2012; 27:605-612. [PMID: 22972585 DOI: 10.1002/tox.20753] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2011] [Accepted: 06/04/2011] [Indexed: 06/01/2023]
Abstract
Tributyltin (TBT), an endocrine-disrupting chemical, is well known to induce imposex in female gastropods. In this study, we assessed the effects of low doses of tributyltin chloride (TBTCl) on dams and their offspring. Pregnant mice were administered by gavage with 0, 1, 10, or 100 μg TBTCl/kg body weight/day from day 6 of pregnancy through the period of lactation. There were no TBT treatment-related deaths or clinical signs of toxicity for dams, and no treatment-related effects on body weight, litter sizes, gestational length of dams, and sex ratio, lactational body weight, postnatal survival, age at eruption of incisors, and eye opening of pups. However, at 100 μg/kg, TBTCl retarded the testes descent of male offspring. Behavioral tests showed a significant delay in cliff-drop aversion response in offspring of 10 and 100 μg/kg groups, but no significant difference in the righting reflex between control and TBT-exposed offspring was detectable. These results indicate that neurobehavioral toxicity seems to be one sensitive indicator to assess the risk of low doses of TBT.
Collapse
Affiliation(s)
- Jiliang Si
- School of Public Health, Shandong University, Jinan, People's Republic of China.
| | | | | | | | | | | |
Collapse
|
22
|
Frye CA, Bo E, Calamandrei G, Calzà L, Dessì-Fulgheri F, Fernández M, Fusani L, Kah O, Kajta M, Le Page Y, Patisaul HB, Venerosi A, Wojtowicz AK, Panzica GC. Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems. J Neuroendocrinol 2012; 24:144-59. [PMID: 21951193 PMCID: PMC3245362 DOI: 10.1111/j.1365-2826.2011.02229.x] [Citation(s) in RCA: 273] [Impact Index Per Article: 22.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Some environmental contaminants interact with hormones and may exert adverse consequences as a result of their actions as endocrine disrupting chemicals (EDCs). Exposure in people is typically a result of contamination of the food chain, inhalation of contaminated house dust or occupational exposure. EDCs include pesticides and herbicides (such as dichlorodiphenyl trichloroethane or its metabolites), methoxychlor, biocides, heat stabilisers and chemical catalysts (such as tributyltin), plastic contaminants (e.g. bisphenol A), pharmaceuticals (i.e. diethylstilbestrol; 17α-ethinylestradiol) or dietary components (such as phytoestrogens). The goal of this review is to address the sources, effects and actions of EDCs, with an emphasis on topics discussed at the International Congress on Steroids and the Nervous System. EDCs may alter reproductively-relevant or nonreproductive, sexually-dimorphic behaviours. In addition, EDCs may have significant effects on neurodevelopmental processes, influencing the morphology of sexually-dimorphic cerebral circuits. Exposure to EDCs is more dangerous if it occurs during specific 'critical periods' of life, such as intrauterine, perinatal, juvenile or puberty periods, when organisms are more sensitive to hormonal disruption, compared to other periods. However, exposure to EDCs in adulthood can also alter physiology. Several EDCs are xenoestrogens, which can alter serum lipid concentrations or metabolism enzymes that are necessary for converting cholesterol to steroid hormones. This can ultimately alter the production of oestradiol and/or other steroids. Finally, many EDCs may have actions via (or independent of) classic actions at cognate steroid receptors. EDCs may have effects through numerous other substrates, such as the aryl hydrocarbon receptor, the peroxisome proliferator-activated receptor and the retinoid X receptor, signal transduction pathways, calcium influx and/or neurotransmitter receptors. Thus, EDCs, from varied sources, may have organisational effects during development and/or activational effects in adulthood that influence sexually-dimorphic, reproductively-relevant processes or other functions, by mimicking, antagonising or altering steroidal actions.
Collapse
Affiliation(s)
- C A Frye
- Department of Psychology, The University at Albany-SUNY, Albany, NY 12222, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
La Merrill M, Birnbaum LS. Childhood obesity and environmental chemicals. THE MOUNT SINAI JOURNAL OF MEDICINE, NEW YORK 2011; 78:22-48. [PMID: 21259261 PMCID: PMC3076189 DOI: 10.1002/msj.20229] [Citation(s) in RCA: 127] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Childhood and adolescent rates of obesity and overweight are continuing to increase in much of the world. Risk factors such as diet composition, excess caloric intake, decreased exercise, genetics, and the built environment are active areas of etiologic research. The obesogen hypothesis, which postulates that prenatal and perinatal chemical exposure can contribute to risk of childhood and adolescent obesity, remains relatively underexamined. This review surveys numerous classes of chemicals for which this hypothesis has been explored. We focus on human data where they exist and also discuss the findings of rodent and cell culture studies. Organochlorine chemicals as well as several classes of chemicals that are peroxisome proliferator-activated receptor agonists are identified as possible risk factors for obesity. Recommendations for future epidemiologic and experimental research on the chemical origins of obesity are also given.
Collapse
|